Life Science Executive Partnering
19-20 May 2026Radisson Blu Scandinavia Hotel, Copenhagen, Denmark Simon RegnellAssociate Director, Search and Evaluation at Novo NordiskSpeaker
Profile
Simon Regnell, MD, PhD, works in Novo Nordisk’s Global Business Development team. In his role, he looks to supplement Novo Nordisk’s product pipeline by bringing in the world’s most promising drugs being developed for diabetes and obesity through inlicensing and acquisitions.
Agenda Sessions
Beyond the Horizon: Next-Generation GLP-1s, Alternatives, and the Future of Diabetes Care and Metabolic Disorders
, 09:10View Session